Abstract
Screening for early detection is a primary way to control breast cancer. The choice of effective screening policies involves substantial uncertainty and difficult tradeoffs among medical costs and the duration and quality of life. In this paper, we study the choice of the age at which screening should begin and the frequency of screening tests. These have been issues of important debate in the health policy community. We address these questions using the framework of cost-utility analysis, as we consider it important to evaluate the outcomes of preventive care in terms of morbidity and quality of life, in addition to survival. After a brief review of background information on breast cancer screening, we introduce cost-utility analysis and its relation with Bayesian decision-making. We then discuss modelling and prior specifications, and carry out a cost-utility evaluation of the currently recommended policy. Finally we compare those to the the Bayes-optimal decision for various values of the exchange rate between dollars and quality of life. We discuss the implications of the results for actual policy decisions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anderson, J.P., Bush, J.W., Chen, M., Dolene, D. (1986) Policy space areas and properties of beneift-cost/utility analysis, Journal of the American Medical Association, 795.
Brookmeyer R., Day, S.D. and Moss, S. (1986) Case control studies for the estimation of the natural history of preclinical disease from screening data, Statistics in Medicine, 5, 127–138.
de Haes, J.C.J.M., et al. (1991) The impact of breast cancer screening programme on quality-adjusted life-years, Int. J. Cancer, 49, 538–544.
Drummond, M.F., Stoddart, G.L., Torrance, G.W. (1987) Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, New York.
Eddy D.M., Hasselblad, V., McGivney, W. and Hendee, W. (1989) The value of mammography screening in women under age 50 years, Journal of the American Medical Association, 259(10), 1512–1519.
Frybeck, S.C. and Thornbury, J.R. (1991) The efficacy of diagnostic imaging, Medical Decision Making, 11, 86–95.
Gramlich, E. (1981) Benefit Cost Analysis of Government Programs. Prentice Hall, Englewood Cliffs, NJ.
Habbema J.D.F., et al. (1986) Age-apecific reduction in breast cancer mortality by screening, JNCI, 77(2), 317–320.
Hatziandreu, E.I., Koplan, J.P., Weinstein, M.C., Caspersen, C.J., Warner, K. (1988) A cost-effectiveness analysis of exercise as a health promotion activity, American Journal of Public Health, 78(11).
Hillner, B.E. and Smith, T.J. (1991) Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer, New England J. Medicine, 324(3), 160–168.
Kamlet M.S. (1991) A Framework for Cost-Utility Analysis of Government Health Care Programs. U.S. Department of Health and Human Services, Washington.
Kirch, R.L.A. and Klein, M. (1974) Examination schedules for breast cancer, Cancer, 33, 1444–1450.
Miller, A.B. (1991) Is routine mammography screening appropriate for women 40–49 years of age?, American Journal of Preventive Medicine, 7, 55–62.
Moolgavkar, S.H., Stevens, R.G. and Lee, J.A.H. (1979) Effect of age on incidence of breast cancer in females, Journal of the National Cancer Institute, 62, 493–501.
NIH Consensus Development Conference (1991) Early stage breast cancer, JAMA, 265(3), 391–395.
Office of Technology Assessment, U.S. Congress (1980) The implications of cost- effectiveness analysis of medical technology, Washington, DC, U.S. Government Printing Office, September.
Parmigiani, G. (1993) On optimal screening ages, J ASA, forthcoming
Parmigiani, G. (1991) Optimal scheduling of medical exams: the case of breast cancer, ISDS, Duke University, Discussion Paper 91–A16.
Pliskin, J.S., Shepard, D.S. and Weinstein, M.C. (1980) Utility functions for life years and health status: theory, assessment, and application, Op. Res., 28, 206–224.
Rapopart, J.F., Robertson, R. and Stuart, B. (1982) Understanding Health Economics. Aspen, Rockwille MD.
Sackett, D.L. and Torrance, G.W. (1978) The utility of different health states as perceived by the general public, Journal of Chronic Disease, 31, 697–704.
Shapiro, S., Venet, W., Strax, P. and Venet, L. (1988) Periodic Screening for Breast Cancer. Johns Hopkins University Press, Baltimore.
Silverberg, E., Boring, C.C. and Squires, T.S. (1990) Cancer Statistics 1990, Ca-A Cancer Journal for Clinicians, 40, 9–26.
Spratt, J.S., Greenberg, R.A. and Heuser, L.S. (1986) Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening, Cancer Research, 46, 970–974.
Torrance, G.W. (1986) Measurement of health state utilities for economic appraisal: A review, Journal of Health Economics, 5(1), 1–30.
Warner, K.E. (1983) Systematic analysis: Cost-benefit and cost-effectiveness techniques in B. Bloom and S. Berki, eds., Cost-Benefit, Cost-Effectiveness, and Other Decision Making Techniques in Health Care Resource Allocation.
Weinstein, M.C. and Fineberg, H. (1980) Clinical Decision Analysis, Saunders, Philadelphia.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag New York, Inc.
About this paper
Cite this paper
Parmigiani, G., Kamlet, M.S. (1993). A Cost-Utility Analysis of Alternative Strategies in Screening for Breast Cancer. In: Gatsonis, C., Hodges, J.S., Kass, R.E., Singpurwalla, N.D. (eds) Case Studies in Bayesian Statistics. Lecture Notes in Statistics, vol 83. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2714-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2714-4_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-94043-4
Online ISBN: 978-1-4612-2714-4
eBook Packages: Springer Book Archive